{"id":"https://openalex.org/W2033285446","doi":"https://doi.org/10.1080/00498250802499459","title":"Toward an improved prediction of humanin vivobrain penetration","display_name":"Toward an improved prediction of humanin vivobrain penetration","publication_year":2008,"publication_date":"2008-11-02","ids":{"openalex":"https://openalex.org/W2033285446","doi":"https://doi.org/10.1080/00498250802499459","mag":"2033285446","pmid":"https://pubmed.ncbi.nlm.nih.gov/18979396"},"language":"en","primary_location":{"id":"doi:10.1080/00498250802499459","doi":"https://doi.org/10.1080/00498250802499459","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00498250802499459","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108716684","display_name":"Scott G. Summerfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"S. G. Summerfield","raw_affiliation_strings":["Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK. scott.g.summerfield@gsk.com","Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK. scott.g.summerfield@gsk.com","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054847813","display_name":"Adam J. Lucas","orcid":"https://orcid.org/0000-0002-8843-3059","observed_orcids":["https://orcid.org/0000-0002-8843-3059"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. J. Lucas","raw_affiliation_strings":["Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026151647","display_name":"Rod A. Porter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. A. Porter","raw_affiliation_strings":["Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011157656","display_name":"Phil Jeffrey","orcid":"https://orcid.org/0000-0003-4131-7218","observed_orcids":["https://orcid.org/0000-0003-4131-7218"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. Jeffrey","raw_affiliation_strings":["Pharmaceuticals II CEDD, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals II CEDD, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065874626","display_name":"Roger N. Gunn","orcid":"https://orcid.org/0000-0003-1181-5769","observed_orcids":["https://orcid.org/0000-0003-1181-5769"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. N. Gunn","raw_affiliation_strings":["Clinical Imaging Centre, Imperial College, Hammersmith Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Imaging Centre, Imperial College, Hammersmith Hospital, London, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011007253","display_name":"K. R. Read","orcid":"https://orcid.org/0000-0002-8536-0130","observed_orcids":["https://orcid.org/0000-0002-8536-0130"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K. R. Read","raw_affiliation_strings":["Biological Chemistry and Drug Discovery, College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Chemistry and Drug Discovery, College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee, UK","institution_ids":["https://openalex.org/I177639307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002159517","display_name":"Alexander J. Stevens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. J. Stevens","raw_affiliation_strings":["Pharmaceuticals II CEDD, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals II CEDD, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023244871","display_name":"Ann Metcalf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. C. Metcalf","raw_affiliation_strings":["Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041797007","display_name":"M. C. Osuna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. C. Osuna","raw_affiliation_strings":["Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072928408","display_name":"Peter J. Kilford","orcid":"https://orcid.org/0000-0002-3333-7350","observed_orcids":["https://orcid.org/0000-0002-3333-7350"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. J. Kilford","raw_affiliation_strings":["School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK","School of Pharmacy & Pharmaceutical Sciences; University of Manchester; Manchester UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"School of Pharmacy & Pharmaceutical Sciences; University of Manchester; Manchester UK","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042140314","display_name":"Jan Passchier","orcid":"https://orcid.org/0000-0003-1958-7748","observed_orcids":["https://orcid.org/0000-0003-1958-7748"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Passchier","raw_affiliation_strings":["Clinical Imaging Centre, Imperial College, Hammersmith Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Imaging Centre, Imperial College, Hammersmith Hospital, London, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040729365","display_name":"Alberto Ruffo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. D. Ruffo","raw_affiliation_strings":["Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5108716684"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":null,"apc_paid":null,"fwci":4.3927,"has_fulltext":false,"cited_by_count":106,"citation_normalized_percentile":{"value":0.93649765,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"38","issue":"12","first_page":"1518","last_page":"1535"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.05209999904036522,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.8519999980926514},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.9679999947547913},{"id":"https://openalex.org/keywords/drug-biodistribution","display_name":"drug biodistribution","score":0.6079999804496765},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.8220000267028809},{"id":"https://openalex.org/keywords/species-comparison","display_name":"species comparison","score":0.4690000116825104},{"id":"https://openalex.org/keywords/passive-diffusion","display_name":"passive diffusion","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pet-radiotracer","display_name":"PET radiotracer","score":0.7239999771118164},{"id":"https://openalex.org/keywords/central-nervous-system-drugs","display_name":"central nervous system drugs","score":0.8109999895095825},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.7358316779136658},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6993438005447388},{"id":"https://openalex.org/C80107235","wikidata":"https://www.wikidata.org/wiki/Q7162625","display_name":"Penetration (warfare)","level":2,"score":0.6523789763450623},{"id":"https://openalex.org/C2777670902","wikidata":"https://www.wikidata.org/wiki/Q492038","display_name":"Human brain","level":2,"score":0.6169655919075012},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.5912008285522461},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.5285640954971313},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.5254035592079163},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5051959156990051},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4941895306110382},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.47865378856658936},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4502781927585602},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4325879216194153},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40568625926971436},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37019583582878113},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.32855281233787537},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.29573556780815125},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.08132344484329224},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C42475967","wikidata":"https://www.wikidata.org/wiki/Q194292","display_name":"Operations research","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002491","descriptor_name":"Central Nervous System Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013552","descriptor_name":"Swine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/00498250802499459","doi":"https://doi.org/10.1080/00498250802499459","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00498250802499459","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},{"id":"pmid:18979396","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18979396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica; the fate of foreign compounds in biological systems","raw_type":"Journal Article"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire_cris_publications/c9c9c56a-366a-4bb3-92f0-f9a00013ece8","doi":null,"is_oa":false,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/c9c9c56a-366a-4bb3-92f0-f9a00013ece8","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Summerfield, S G, Lucas, A J, Porter, R A, Jeffrey, P, Gunn, R N, Read, K R, Stevens, A J, Metcalf, A C, Osuna-Cabello, M C, Kilford, P J, Passchier, J & Ruffo, A D 2008, 'Toward an improved prediction of human in vivo brain penetration', Xenobiotica, vol. 38, no. 12, pp. 1518-1535. https://doi.org/10.1080/00498250802499459","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9074000120162964,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":72,"referenced_works":["https://openalex.org/W56771511","https://openalex.org/W160998396","https://openalex.org/W177825183","https://openalex.org/W312766858","https://openalex.org/W1567238908","https://openalex.org/W1674686464","https://openalex.org/W1787663985","https://openalex.org/W1928148058","https://openalex.org/W1965825054","https://openalex.org/W1968857994","https://openalex.org/W1970263371","https://openalex.org/W1979946819","https://openalex.org/W1981860915","https://openalex.org/W1982605749","https://openalex.org/W1987741625","https://openalex.org/W1990250882","https://openalex.org/W1990644324","https://openalex.org/W1992381398","https://openalex.org/W1994206407","https://openalex.org/W1997406173","https://openalex.org/W2002831316","https://openalex.org/W2006669174","https://openalex.org/W2008779596","https://openalex.org/W2009413301","https://openalex.org/W2028194176","https://openalex.org/W2033429303","https://openalex.org/W2033827989","https://openalex.org/W2039297169","https://openalex.org/W2042099048","https://openalex.org/W2042692746","https://openalex.org/W2046232117","https://openalex.org/W2049819189","https://openalex.org/W2058780134","https://openalex.org/W2059073031","https://openalex.org/W2066735646","https://openalex.org/W2069844783","https://openalex.org/W2076560915","https://openalex.org/W2080374657","https://openalex.org/W2080970615","https://openalex.org/W2095100173","https://openalex.org/W2096045848","https://openalex.org/W2106588887","https://openalex.org/W2107798346","https://openalex.org/W2108141803","https://openalex.org/W2112278807","https://openalex.org/W2112893277","https://openalex.org/W2114495485","https://openalex.org/W2114702980","https://openalex.org/W2115555476","https://openalex.org/W2117024164","https://openalex.org/W2119958813","https://openalex.org/W2127298328","https://openalex.org/W2134756034","https://openalex.org/W2138656355","https://openalex.org/W2144391411","https://openalex.org/W2144687678","https://openalex.org/W2146393360","https://openalex.org/W2148992136","https://openalex.org/W2149016411","https://openalex.org/W2150755991","https://openalex.org/W2152502995","https://openalex.org/W2156445661","https://openalex.org/W2158900181","https://openalex.org/W2160261929","https://openalex.org/W2163284329","https://openalex.org/W2164638699","https://openalex.org/W2169525945","https://openalex.org/W2171671443","https://openalex.org/W2322470125","https://openalex.org/W2322933999","https://openalex.org/W2340991487","https://openalex.org/W2949104129"],"related_works":["https://openalex.org/W2006669174","https://openalex.org/W6997134081","https://openalex.org/W7099438947","https://openalex.org/W2253346903","https://openalex.org/W2070393066","https://openalex.org/W4391533041","https://openalex.org/W4285223654","https://openalex.org/W2802837887","https://openalex.org/W2794720365","https://openalex.org/W3135094597"],"abstract_inverted_index":{"The":[0],"penetration":[1,69,104,210],"of":[2,12,16,26,63,67,85,95,102,139,143,145,154,160,208],"drugs":[3,165,198],"into":[4,28,88],"the":[5,14,20,24,38,59,64,83,96,100,140,146,189,203],"central":[6,147,162],"nervous":[7,148,163],"system":[8,149,164],"is":[9,37,137,192],"a":[10],"composite":[11],"both":[13],"rate":[15],"drug":[17,45],"uptake":[18],"across":[19,105,124,188,211],"blood-brain":[21,190],"barrier":[22,191],"and":[23,111,131,166,179,201],"extent":[25,101],"distribution":[27],"brain":[29,68,103,112,122,209],"tissue":[30,113],"compartments.":[31],"Clinically,":[32],"positron":[33],"emission":[34],"tomography":[35],"(PET)":[36],"primary":[39],"technique":[40],"for":[41,61,196,205],"deriving":[42],"information":[43],"on":[44,99],"biodistribution":[46],"as":[47,49],"well":[48,170],"target":[50],"receptor":[51],"occupancy.":[52],"In":[53,151],"contrast,":[54],"rodent":[55],"models":[56],"have":[57],"formed":[58],"basis":[60],"much":[62],"current":[65],"understanding":[66],"within":[70],"pharmaceutical":[71],"Drug":[72],"Discovery.":[73],"Linking":[74],"these":[75],"two":[76,94],"areas":[77],"more":[78],"effectively":[79],"would":[80],"greatly":[81],"improve":[82],"translation":[84],"candidate":[86],"compounds":[87],"therapeutic":[89],"agents.":[90],"This":[91],"paper":[92],"examines":[93],"major":[97],"influences":[98],"species,":[106],"namely":[107],"plasma":[108],"protein":[109],"binding":[110],"binding.":[114],"An":[115],"excellent":[116],"correlation":[117],"was":[118],"noted":[119],"between":[120],"unbound":[121],"fractions":[123],"species":[125],"(R(2)":[126],">":[127],"0.9":[128],"rat,":[129],"pig,":[130],"human,":[132],"n":[133],"=":[134],"21),":[135],"which":[136],"indicative":[138],"high":[141],"degree":[142],"conservation":[144],"environment.":[150],"vitro":[152],"estimates":[153],"human":[155],"brain-blood":[156],"or":[157],"brain-plasma":[158],"ratios":[159],"marketed":[161],"PET":[167,178],"tracers":[168],"agree":[169],"with":[171],"in":[172,199],"vivo":[173],"values":[174],"derived":[175],"from":[176],"clinical":[177],"post-mortem":[180],"studies.":[181],"These":[182],"results":[183],"suggest":[184],"that":[185],"passive":[186],"diffusion":[187],"an":[193],"important":[194],"process":[195],"many":[197],"humans":[200],"highlights":[202],"possibility":[204],"improved":[206],"prediction":[207],"species.":[212]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}